Zomedica Corp. Business Acquisition, Pro Forma Net Income (Loss)
Zomedica Corp. (ZOMDF) reported Business Acquisition, Pro Forma Net Income (Loss) of -$18.42 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2022-03-01
- Zomedica Corp. business acquisition, pro forma net income (loss) for fiscal 2021 was -$18.42M.
- Zomedica Corp. business acquisition, pro forma net income (loss) for fiscal 2020 was -$17.34M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|
| 2021-12-31 | -$18.42M 10-K · filed 2022-03-01 |
| 2020-12-31 | -$17.34M 10-K · filed 2022-03-01 |